recast-jats-buildd8e1462159jitcJ Immunother CancerjitcJournal for ImmunoTherapy of CancerJ Immunother CancerJ Immunother Cancer2051-1426BMJ Publishing Group Ltdjitc-020-0755-1corr110.1136/jitc-020-0755-1corr1/jitc/8/1/e0755-1corr1.atomCorrectionOpen accessSpecial collectionsOpen accessCorrection: Metastatic breast cancers have reduced immune cell recruitment but harbour increased macrophages relative to their matched primary tumors 420202642020201220192012201981e0755-1corr1© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.2020http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.special-featureunlocked

Zhu L, Narloch JL, Onkar S, et al Metastatic breast cancers have reduced immune cell recruitment but harbor increased macrophages relative to their matched primary tumors. J Immuno Cancer 2019;7:265. doi: 10.1186/s40425-019-0755-1

In this article, the funding statement is missing information related to the Pennsylvania Department of Health. The correct funding statement is below:

We acknowledge funding support from Breast Cancer Research Foundation (AVL, SO, LAE), National Cancer Institute of the National Institutes of Health (P30CA047904), Fashion Footwear Association of New York (FFANY), the Nicole Meloche Memorial Breast Cancer Research Foundations, the Penguins Alumni Foundation, the Shear Family Foundation, TL-1 CTSA Pre-Doctoral Training Grant (5TL1TR001116–03), Duke Cancer Institute Core Grant (P30CA014236), and Magee-Womens Research Institute and Foundation and the Pennsylvania Department of Health which specifically disclaims responsibility for any analysis, interpretations, or conclusions. AVL and SO are recipients of Scientific Advisory Council awards from Susan G. Komen for the Cure, and are Hillman Foundation Fellows. LAE is a Hillman Scholar for Innovative Cancer Research.